Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep - Notice of Annual General Meeting/Proxy Form (ASX:IMM)

Immutep Limited (the Company) is convening its 2020 Annual General Meeting (AGM) at 10:30 am (AEDT) on Tuesday, 27th October 2020. Due to the COVID-19 pandemic and related issues, the AGM will be...read more

Immutep - Appendix 4G & Corporate Governance Statement (ASX:IMM)

To view the appendix, download the attached PDF.

Immutep - Annual Report to shareholders (ASX:IMM)

To view the report, download the attached PDF.

Immutep - Improving results from stage 1 of TACTI-002 ph II trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) announces new interim data from its ongoing Phase II TACTI-002 study. The data was presented in two poster presentations at the ESMO Virtual Congress 2020 on...read more

Immutep reports improving results from INSIGHT-004 trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to report further interim data from its ongoing INSIGHT-004 Phase I clinical trial. The data were presented at the ESMO Virtual Congress 2020 on 1...read more

Immutep - Change in substantial holding (ASX:IMM)

To view the Notice of change of interests of substantial holder, download the attached PDF.

Immutep - 2020 AGM & Key Dates (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) advises that it intends to hold its 2020 Annual General Meeting, (AGM) on Tuesday, 27 October 2020 commencing at 10.30am (AEDT). The Company further advis...read more

IVE Group - S&P DJI Announces September 2020 Quarterly Rebalance (ASX:IGL)

S&P Dow Jones Indices (“S&P DJI”) announced today the changes in the S&P/ASX Indices, effective at the open of trading on September 21, 2020. Please note that in this announc...read more

Immutep & Monash Uni receive funding grant for LAG-3 Research (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to announce that the Australian Research Council (ARC) has awarded Immutep and research partner Monash University a A$671,427 grant under the ARC&...read more

Immutep announces new data to be presented at ESMO for eftilagimod alpha (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, pl...read more

IVE Group - 2020 Corporate Governance Statement and Appendix 4G (ASX:IGL)

To view the appendix, download the attached PDF.

IVE Group - Results for the year ending 30 June 2020 (ASX:IGL)

IVE Group Limited (IVE or the Company) today is pleased to announce its results for the 12 months ended 30 June 2020 (FY20), a period impacted by the unprecedented volatility and uncertainty as a re...read more

IVE Group - FY20 Results Presentation (ASX:IGL)

To view the presentation, download the attached PDF.

IVE Group - Appendix 4E & Financial Statements - Year ended 30 June 2020 (ASX:IGL)

This information should be read in conjunction with the 30 June 2020 Year End Financial Report of IVE Group Limited and its controlled entities and any public announcements made in the period by IVE...read more